These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 26521842)
1. [Type 2 diabetes prevention. Experts' Group position paper endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]. Walicka M; Chomiuk T; Filipiak KJ; Mamcarz A; Olszanecka-Glinianowicz M; Wożakowska-Kapłon B; Wyleżoł M; Franek E Kardiol Pol; 2015; 73(10):949-57. PubMed ID: 26521842 [TBL] [Abstract][Full Text] [Related]
2. [Fondaparinux in the treatment of acute coronary syndromes in Poland--from theory to practice. Experts' group position paper endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]. Filipiak KJ; Wożakowska-Kapłon B; Witkowski A; Gierlotka M; Opolski G; Mamcarz A Kardiol Pol; 2015; 73(10):943-8. PubMed ID: 26521893 [No Abstract] [Full Text] [Related]
3. [Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure]. Mamcarz A; Filipiak KJ; Drożdż J; Nessler J; Tykarski A; Niemczyk M; Wożakowska-Kapłon B Kardiol Pol; 2015; 73(3):225-32. PubMed ID: 25791979 [No Abstract] [Full Text] [Related]
4. Recommendation for the management of dyslipidemia in Poland - Third Declaration of Sopot. Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. Szymański FM; Barylski M; Cybulska B; Wożakowska-Kapłon B; Krasiński Z; Mamcarz A; Widecka K; Płatek AE; Dudek D; Mickiewicz A; Kobayashi A; Dzida G; Grajek S; Wełnicki M; Zubilewicz T; Ufnal M; Hering D; Mizia-Stec K; Kasprzak J; Koziński M; Imiela J; Narkiewicz K; Gorczyca I; Postuła M; Jaguszewski MJ; Filipiak KJ Cardiol J; 2018; 25(6):655-665. PubMed ID: 30600830 [No Abstract] [Full Text] [Related]
5. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. ; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E Can J Cardiol; 2011; 27(2):e1-e33. PubMed ID: 21459257 [TBL] [Abstract][Full Text] [Related]
6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
7. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109 [TBL] [Abstract][Full Text] [Related]
8. The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. Zarnke KB; McAlister FA; Campbell NR; Levine M; Schiffrin EL; Grover S; McKay DW; Myers MG; Wilson TW; Rabkin SW; Feldman RD; Burgess E; Bolli P; Honos G; Lebel M; Mann K; Abbott C; Tobe S; Petrella R; Touyz RM; Can J Cardiol; 2002 Jun; 18(6):604-24. PubMed ID: 12107419 [TBL] [Abstract][Full Text] [Related]
9. Diet and exercise in the prevention of diabetes. Ryan DH; Int J Clin Pract Suppl; 2003 Mar; (134):28-35. PubMed ID: 12793595 [TBL] [Abstract][Full Text] [Related]
10. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). ; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E Can J Cardiol; 2011; 27(2):124-31. PubMed ID: 21459258 [TBL] [Abstract][Full Text] [Related]
11. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes. Lau DC; Teoh H Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857 [TBL] [Abstract][Full Text] [Related]
12. [Strategy and practice in the prevention of type-2 diabetes]. Liou YM Hu Li Za Zhi; 2008 Feb; 55(1):70-4. PubMed ID: 18270935 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular prevention in patients with diabetes and prediabetes. Anselmino M; Gohlke H; Mellbin L; Rydén L Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310 [TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design. Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J Trials; 2015 Nov; 16():496. PubMed ID: 26530718 [TBL] [Abstract][Full Text] [Related]
15. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
17. Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot. Szymański FM; Mickiewicz A; Dzida G; Gorczyca-Głowacka I; Kozłowski D; Widecka K; Krasiński Z; Kobayashi A; Hering D; Mizia-Stec K; Kasprzak JD; Zubilewicz T; Narkiewicz K; Koziński M; Płatek AE; Ryś-Czaporowska A; Chełstowska B; Grajek S; Wełnicki M; Mamcarz A; Barylski M; Wożakowska-Kapłon B; Jaguszewski MJ; Gruchała M; Filipiak KJ Cardiol J; 2022; 29(1):1-26. PubMed ID: 34811718 [No Abstract] [Full Text] [Related]
18. [Bivalirudine use in the acute myocardial infarction in patients undergoing percutaneous coronary interventions: consensus statement of experts from the Cardiovascular Pharmacotherapy Working Group and the Association on Cardiovascular Interventions of the Polish Cardiac Society]. Wożakowska-Kapłon B; Lesiak M; Ochała A; Witkowski A; Filipiak KJ Kardiol Pol; 2014; 72(8):761-5. PubMed ID: 25155855 [No Abstract] [Full Text] [Related]
19. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Li G; Zhang P; Wang J; Gregg EW; Yang W; Gong Q; Li H; Li H; Jiang Y; An Y; Shuai Y; Zhang B; Zhang J; Thompson TJ; Gerzoff RB; Roglic G; Hu Y; Bennett PH Lancet; 2008 May; 371(9626):1783-9. PubMed ID: 18502303 [TBL] [Abstract][Full Text] [Related]
20. [The Acapulco Declaration: a proposal to reduce incidence of diabetes in México]. Aguilar-Salinas CA; Gómez-Pérez FJ Rev Invest Clin; 2006; 58(1):71-7. PubMed ID: 16789601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]